Material-enabled stem cell-derived exosome as well as preparation method and application thereof
By culturing mesenchymal stem cells on an N/VE-cadherin-Fc substrate and applying staged shear stress, exosomes were dynamically cultured and prepared. This solved the problem that existing exosome preparation methods could not achieve multi-target synergistic therapy, significantly improved the yield and function of exosomes, and enhanced the therapeutic effect of central nervous system injury.
Patent Information
- Application Number
- CN202610281110.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2026-03-09
- Publication Date
- 2026-06-02
AI Technical Summary
In the existing technology, the methods for preparing exosomes derived from mesenchymal stem cells have failed to effectively achieve multi-target synergistic treatment of central nervous system injury, lack systematic optimization of exosome preparation conditions, and the function of exosomes depends on the static effector characteristics of the mother cell, and cannot be dynamically adjusted according to changes in the lesion microenvironment.
A method combining neurovascular specific N/VE-cad-Fc substrates and dynamic culture was adopted to prepare exosomes by culturing mesenchymal stem cells on substrates coated with N/VE-cadherin-Fc fusion protein to form cadherin-enabled cell aggregates, and applying staged shear stress and dynamic culture.
It significantly increased the production of exosomes and enriched miRNAs that promote nerve regeneration, angiogenesis and anti-inflammation, achieving multi-target synergistic treatment of central nervous system injury and improving the therapeutic effect.